【联邦制药:UBT48128片获美国FDA临床试验批准】联邦制药公告,公司全资附属公司联邦生物科技有限公司自主研发的1类创新药UBT48128片,关于超重或肥胖适应症及2型糖尿病适应症的新药临床试验注册申请获美国食品药品监督管理局批准。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.